Industry Expertise

Medical Technology

The U.S. healthcare segment is poised for dramatic changes as a result of new political realities. Expansions in coverage for uninsured Americans, new payors, changing regulations, and increasing pressures to control spiraling costs will create both opportunities and threats for medical manufacturers and distributors.

From a strategic point of view, business owners in the fragmented medical technology industry have opportunities to grow through the acquisition of smaller companies, or to sell to larger consolidators. Access to capital will be a key factor in determining which companies remain independent, and which will not. Carbide Partners has the experience to assist a variety of participants in the medtech sector:

  • Medical contract manufacturers
  • Manufacturers of components and disposables
  • Medical device companies
  • Producers of durable medical equipment
  • Providers of diagnostic products, instruments, reagents, lab equipment and other supplies
  • Distributors of medical products and supplies


Mark Kammert, Managing Partner and the head of Carbide Partners’ Medical Technology Group, led the acquisition of a leading medical contract manufacturer on behalf of a private equity sponsor in 2004. Mr. Kammert raised the initial senior debt, mezzanine and equity co-investor financing for the acquisition and orchestrated several refinancings to fund acquisitions by the company in subsequent years.

Pursuing a strategic plan to build the business into a full-service medical outsourcing company, Mr. Kammert helped identify and review over 60 acquisition candidates. Following the completion of four successful add-on transactions, Mr. Kammert helped lead the sale of the company to a strategic buyer in 2008, realizing a significant capital gain for the company’s private equity investors. See Case Studies: Acquisitions & Corporate Sale — Medical Manufacturing for additional details.